Clinical Trials Browser

Phase 2/3 × Terminated × Thiotepa × Clear all

NCT00448266 2021-01-22

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Phase 2/3 Terminated

Breast Neoplasms